Published in Nature · View the paper (DOI)
Researchers have determined the three-dimensional structure of glycine transporter GlyT1, providing insight into its regulation and potential inhibition. This discovery could lead to effective drugs that inhibit GlyT1 function, with major implications for treating schizophrenia and other mental disorders.
Coverage from 2 institutions